The need to define treatment goals for systemic lupus erythematosus

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

(2014) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

(2013) Daniel J Wallace et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic

(2013) V Golder et al.   LUPUS

Recent insights into the genetic basis of systemic lupus erythematosus

(2012) Ornella Josephine Rullo et al.   ANNALS OF THE RHEUMATIC DISEASES

Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s

(2012) Anselm Mak et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period

(2011) Amanda J. Steiman et al.   ARTHRITIS CARE & RESEARCH

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study

(2011) Mandana Nikpour et al.   ARTHRITIS RESEARCH & THERAPY

Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome

(2010) A. J. STEIMAN et al.   JOURNAL OF RHEUMATOLOGY

Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus

(2010) J. Nossent et al.   LUPUS

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

(2009) Daniel J. Wallace et al.   ARTHRITIS AND RHEUMATISM

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

(2009) Paolo Verdecchia et al.   LANCET

Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus

(2008) Murray B. Urowitz et al.   JOURNAL OF RHEUMATOLOGY